Tralokinumab

Records for this ingredient, by country (identity only).

ATC D11AH07 · 7 markets · 13 records

Tralokinumab 7 markets · 13 records Forms

Filters

MarketUS 2 GB 2 CA 2 ES 2 JP 2 FR 2 EU 1

Strength

US 2 records · 2 shown of 2 Source openFDA NDC Directory · Data as of 2026-10-23

300 mg/2 mLinjectionAdbry also in GB·JP·FR
150 mg per mL / per unit basis not statedinjectionAdbry

GB 2 records · 2 shown of 2 Source NHSBSA dm+d · Data as of 2026-10-19

300 mg/2 mLinjectionAdtralza 300mg/2ml solution for injection pre-filled pens also in US·JP·FR
150 mg/1 mLinjectionAdtralza 150mg/1ml solution for injection pre-filled syringes also in JP·FR

CA 2 records · 2 shown of 2 Source Health Canada Drug Product Databas · Data as of 2026-10-23

150 mg per mL / per unit basis not statedliquidADTRALZA
150 mg/1 mLliquidADTRALZA

ES 2 records · 2 shown of 2 Source CIMA (AEMPS) · Data as of live

150 mg per mL / per unit basis not statedinjectionADTRALZA PRECARGADA
300 mg per mL / per unit basis not statedinjectionADTRALZA PRECARGADA

JP 2 records · 2 shown of 2 Source 厚生労働省薬価基準収載品目リスト · Data as of 2026-11-01

300 mg/2 mLinjectionアドトラーザ皮下注300mgペン also in US·GB·FR
150 mg/1 mLinjectionアドトラーザ皮下注150mgシリンジ also in GB·FR

FR 2 records · 2 shown of 2 Source Base de données publique des médic · Data as of 2026-11-03

300 mg/2 mLinjectionADTRALZA 300 mg, solution injectable en stylo prérempli also in US·GB·JP
150 mg/1 mLinjectionADTRALZA 150 mg, solution injectable en seringue préremplie also in GB·JP

EU 1 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名ADTRALZA ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

Side-by-side table

Strength / form / release	US	GB	CA	ES	JP	EU	FR
300 mg/2 mL injection	Adbry	Adtralza 300mg/2ml solution for injection pre-filled pens	not recorded	not recorded	アドトラーザ皮下注300mgペン	not recorded	ADTRALZA 300 mg, solution injectable en stylo prérempli
150 mg/1 mL injection	not recorded	Adtralza 150mg/1ml solution for injection pre-filled syringes	not recorded	not recorded	アドトラーザ皮下注150mgシリンジ	not recorded	ADTRALZA 150 mg, solution injectable en seringue préremplie
150 mg per mL / per unit basis not stated cannot compare injection	Adbry	not recorded	not recorded	ADTRALZA PRECARGADA	not recorded	not recorded	not recorded
150 mg per mL / per unit basis not stated cannot compare liquid	not recorded	not recorded	ADTRALZA	not recorded	not recorded	not recorded	not recorded
150 mg/1 mL liquid	not recorded	not recorded	ADTRALZA	not recorded	not recorded	not recorded	not recorded
300 mg per mL / per unit basis not stated cannot compare injection	not recorded	not recorded	not recorded	ADTRALZA PRECARGADA	not recorded	not recorded	not recorded
not disclosed unknown	not recorded	not recorded	not recorded	not recorded	not recorded	ADTRALZA	not recorded

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

2 more strength/form rows are recorded only in GB · JP · EU · FR and are not shown in this table. Hay 2 filas de concentración/forma registradas solo en GB · JP · EU · FR que no se muestran en esta tabla. 另有 2 个规格/剂型仅在 GB · JP · EU · FR 有记录（未在本表显示）。另有 2 個規格/劑型僅在 GB · JP · EU · FR 有記錄（未在本表顯示）。

“not disclosed” means the source does not publish the strength — it does not mean the product has none.